Advances in immunotherapy for recurrent and metastatic cervical cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 517-520, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-954314
ABSTRACT
Immunotherapy mainly includes simple immunotherapy (immune checkpoint inhibitor, therapeutic human papillomavirus vaccine, adoptive T cell therapy, double immunotherapy, etc.) , immunotherapy combined with other treatments (such as chemotherapy, antiangiogenic therapy, radiotherapy, etc.) . The continuous development of immunotherapy and the improvement of treatment scheme have improved the survival and prognosis of patients, and provided new ideas for the diagnosis and treatment of recurrent and metastatic cervical cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS